Creative Medical Technology Holdings Issues Letter to Shareholders
Creative Medical Technology Holdings Issues Letter to Shareholders Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026 GlobeNewswire October 27, 2025 PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company […]